A Phase 1b Clinical Trial of CRISPR Delivered Anti-BCMA Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Multiple Myeloma
NCT07340853 · RECRUITING · Phase 1
We track 1 ClinicalTrials.gov studies led by Thomas Martin Md. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Thomas Martin Md.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Thomas Martin Md currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Thomas Martin Md conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Thomas Martin Md currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.